Protara Therapeutics, Inc. (TARA)
NASDAQ: TARA · Real-Time Price · USD
2.880
-0.100 (-3.36%)
At close: Jun 27, 2025, 4:00 PM
2.820
-0.060 (-2.08%)
After-hours: Jun 27, 2025, 6:08 PM EDT

Protara Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Market Capitalization
111253213076271
Upgrade
Market Cap Growth
241.62%1089.52%-29.43%-60.18%-72.06%-
Upgrade
Enterprise Value
-42177-47-70-55106
Upgrade
Last Close Price
2.985.281.882.686.7524.21
Upgrade
PB Ratio
0.731.520.310.300.471.36
Upgrade
P/TBV Ratio
0.701.520.310.300.571.60
Upgrade
Debt / Equity Ratio
0.030.030.080.060.050.01
Upgrade
Quick Ratio
17.7715.5410.7114.7821.3757.84
Upgrade
Current Ratio
18.0315.7111.1715.0121.6658.13
Upgrade
Return on Equity (ROE)
-41.88%-37.88%-47.44%-49.96%-26.17%-34.48%
Upgrade
Return on Assets (ROA)
-27.16%-23.59%-28.36%-16.42%-15.80%-21.07%
Upgrade
Return on Capital (ROIC)
-28.40%-25.04%-29.91%-16.91%-16.07%-21.72%
Upgrade
Earnings Yield
-40.87%-17.59%-189.67%-218.41%-62.30%-12.52%
Upgrade
FCF Yield
-36.22%-14.15%-176.45%-88.01%-46.28%-8.95%
Upgrade
Buyback Yield / Dilution
-145.71%-81.73%-0.64%-0.24%-55.28%-180.66%
Upgrade
Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q